Search results: Sage Journals

Open accessResearch articleFirst published 2025

Impact of dipeptidyl peptidase-4 inhibitors on incidence of colorectal cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

Rongrong Fu, Jingqi Chen, Yingying Fang [...]

Therapeutic Advances in Drug Safety

Restricted accessCase reportFirst published August, 2023

Bullous Pemphigoid Associated With Dipeptidyl Peptidase-4 Inhibitors: A Case Report and Review of Current Evidence

Faten Hadjkacem, Hamdi Frikha, Khouloud Boujelben [...]

Hospital Pharmacy

Open accessResearch articleFirst published July, 2022

Biochemical Investigation of Therapeutic Potentials of Plant-Based Bioactive Compounds as Stimulators of Glucagon like peptide-1 Secretion

Areeba Javed, Ayman Muzammal, Muhammad Sajid Hamid Akash [...]

Dose-Response

Restricted accessResearch articleFirst published October, 2024

Utilization of Glucagon-Like Peptide-1 Receptor Agonist and Dipeptidyl Peptidase-4 Inhibitors at the Veterans Health Administration

Aditya Krishnan, Sowmya K. Suryanarayanan, Ishak A. Mansi

Journal of Pharmacy Technology

Free accessResearch articleFirst published October, 2011

Combination Therapy with a Dipeptidyl Peptidase-4 Inhibitor and a Proton Pump Inhibitor Induces β-Cell Neogenesis from Adult Human Pancreatic Duct Cells Implanted in Immunodeficient Mice

Wilma L. Suarez-Pinzon, Alex Rabinovitch

Cell Transplantation

Restricted accessResearch articleFirst published April, 2021

Outcomes Associated With the Adjunctive Use of Dipeptidyl Peptidase-4 Inhibitors With Insulin Versus Other Antihyperglycemic Medications in Patients With Prediabetes or Diabetes After Cardiac Surgery

Lisa Clark, Erin Weeda, Mary Lewis Griffin [...]

Journal of Pharmacy Practice

Restricted accessReview articleFirst published January, 2025

Association of dipeptidyl peptidase-4 with Alzheimer's disease: A new therapeutic prospect

Xinyi Wang, Li Chen

Journal of Alzheimer’s Disease

Open accessResearch articleFirst published 2022

Association of dipeptidyl peptidase-4 inhibitor use and the risk of asthma development among type 2 diabetes patients

Peng-Fei Li, Chi-Hsiang Chung, Jhih-Syuan Liu [...]

Therapeutic Advances in Respiratory Disease

Open accessResearch articleFirst published 2026

Dipeptidyl peptidase-4 inhibitors are associated with a lower risk of osteoarthritis in patients with type 2 diabetes

Yu-Hsiu Chen, Virginia Byers Kraus, Yu-Sheng Chang [...]

Therapeutic Advances in Musculoskeletal Disease

Restricted accessReview articleFirst published January, 2026

Incidence of dementia in patients with type 2 diabetes using SGLT2 inhibitors versus GLP-1 receptor agonists or DPP-4 inhibitors: A systematic review and meta-analysis of cohort studies

Pedro Henrique Milori, Larissa Maria Armelin, Antônio Mutarelli [...]

Journal of Alzheimer’s Disease

Open accessResearch articleFirst published 2025

Impact of dipeptidyl peptidase-4 inhibitors on incidence of colorectal cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

Rongrong Fu, Jingqi Chen, Yingying Fang [...]

Therapeutic Advances in Drug Safety

Restricted accessCase reportFirst published August, 2023

Bullous Pemphigoid Associated With Dipeptidyl Peptidase-4 Inhibitors: A Case Report and Review of Current Evidence

Faten Hadjkacem, Hamdi Frikha, Khouloud Boujelben [...]

Hospital Pharmacy

Open accessResearch articleFirst published July, 2022

Biochemical Investigation of Therapeutic Potentials of Plant-Based Bioactive Compounds as Stimulators of Glucagon like peptide-1 Secretion

Areeba Javed, Ayman Muzammal, Muhammad Sajid Hamid Akash [...]

Dose-Response

Restricted accessResearch articleFirst published October, 2024

Utilization of Glucagon-Like Peptide-1 Receptor Agonist and Dipeptidyl Peptidase-4 Inhibitors at the Veterans Health Administration

Aditya Krishnan, Sowmya K. Suryanarayanan, Ishak A. Mansi

Journal of Pharmacy Technology

Free accessResearch articleFirst published October, 2011

Combination Therapy with a Dipeptidyl Peptidase-4 Inhibitor and a Proton Pump Inhibitor Induces β-Cell Neogenesis from Adult Human Pancreatic Duct Cells Implanted in Immunodeficient Mice

Wilma L. Suarez-Pinzon, Alex Rabinovitch

Cell Transplantation

Restricted accessResearch articleFirst published April, 2021

Outcomes Associated With the Adjunctive Use of Dipeptidyl Peptidase-4 Inhibitors With Insulin Versus Other Antihyperglycemic Medications in Patients With Prediabetes or Diabetes After Cardiac Surgery

Lisa Clark, Erin Weeda, Mary Lewis Griffin [...]

Journal of Pharmacy Practice

Restricted accessReview articleFirst published January, 2025

Association of dipeptidyl peptidase-4 with Alzheimer's disease: A new therapeutic prospect

Xinyi Wang, Li Chen

Journal of Alzheimer’s Disease

Open accessResearch articleFirst published 2022

Association of dipeptidyl peptidase-4 inhibitor use and the risk of asthma development among type 2 diabetes patients

Peng-Fei Li, Chi-Hsiang Chung, Jhih-Syuan Liu [...]

Therapeutic Advances in Respiratory Disease

Open accessResearch articleFirst published 2026

Dipeptidyl peptidase-4 inhibitors are associated with a lower risk of osteoarthritis in patients with type 2 diabetes

Yu-Hsiu Chen, Virginia Byers Kraus, Yu-Sheng Chang [...]

Therapeutic Advances in Musculoskeletal Disease

Restricted accessReview articleFirst published January, 2026

Incidence of dementia in patients with type 2 diabetes using SGLT2 inhibitors versus GLP-1 receptor agonists or DPP-4 inhibitors: A systematic review and meta-analysis of cohort studies

Pedro Henrique Milori, Larissa Maria Armelin, Antônio Mutarelli [...]

Journal of Alzheimer’s Disease